About AERI

Aerie is a clinical-stage pharmaceutical company focused on the discovery, development and commercialization of first-in-class therapies for the treatment of patients with glaucoma and other diseases of the eye. Aerie recently reported the successful results of its second Phase 3 registration trial in the United States named Rocket 2, where the primary efficacy endpoint was to demonstrate non-inferiority of IOP lowering for Rhopressa compared to timolol. Rocket 3, a 12-month safety-only study, is currently in progress, and Aerie has recently commenced a fourth Phase 3 trial for Rhopressa, named Rocket 4. Aerie also completed in 2014 a Phase 2b clinical trial in which Roclatan met the primary efficacy endpoint, demonstrating the statistical superiority of Roclatan to each of its components, and recently commenced the first Phase 3 registration trial for Roclatan, named Mercury 1. Aerie also recently announced research collaborations with GrayBug, Inc. and Ramot at Tel Aviv University as it further builds its pipeline for future growth.
Primary Exchange: NASDAQ
SIC Pharmaceutical Preparations
NAICS Biological Product (except Diagnostic) Manufacturing

AERI is a Holding In These ETFs:

ETF Ticker ETF Name Net Assets Net Assets Raw # Holdings # Holdings Raw Weight Weight Raw Market Value Market Value Raw
BIB ProShares Ultra Nasdaq Biotechnology 199.3 M 1.99301E+08 230 230 0.06% 0.00061593 253 K 253170
UBIO Proshares UltraPro Nasdaq Biotechnology 25.6 M 2.5617E+07 225 225 0.04% 0.000408221 33 K 33008
URTY ProShares UltraPro Russell2000 81.1 M 8.1125E+07 2,012 2012 0.01% 0.000129283 33 K 32558
UWM ProShares Ultra Russell2000 149.7 M 1.49742E+08 2,011 2011 0.02% 0.000187069 60 K 60210
XPH SPDR S&P Pharmaceuticals ETF 192.1 M 1.921E+08 42 42 1.74% 0.0174331 3.3 M 3345110
TILT FlexShares Mornigstar US Market Factors Tilt Index Fund ETF 1.4 B 1.39355E+09 2,245 2245 0.0% 4.4E-05 60 K 60142
VB Vanguard Small-Cap ETF 25.7 B 2.57E+10 1,401 1401 0.03% 0.00027 7.1 M 7114920
VBR Vanguard Small-Cap Value ETF 13.6 B 1.36E+10 855 855 0.05% 0.00051 7.0 M 6986370
VHT Vanguard Health Care ETF 9.1 B 9.1E+09 386 386 0.02% 0.00023 2.1 M 2110950
VTHR Vanguard Russell 3000 ETF 479.5 M 4.795E+08 3,004 3004 0.0% 3E-05 13 K 13033
VTI Vanguard Total Stock Market ETF 119.5 B 1.195E+11 3,575 3575 0.0% 4E-05 4.6 M 4590790
VTWG Vanguard Russell 2000 Growth ETF 307.1 M 3.071E+08 1,329 1329 0.09% 0.0009 277 K 277071
VTWO Vanguard Russell 2000 ETF 1.5 B 1.5E+09 2,029 2029 0.05% 0.00046 685 K 685234
VXF Vanguard Extended Market ETF 7.3 B 7.3E+09 3,266 3266 0.02% 0.00017 1.3 M 1250890
SCHA Schwab U.S. Small-Cap ETF 8.1 B 8.14785E+09 1,745 1745 0.03% 0.0003 2.6 M 2632185
SCHB Schwab U.S. Broad Market ETF 15.3 B 1.52769E+10 2,459 2459 0.0% 0 479 K 479182
IBB iShares Nasdaq Biotechnology Index Fund 7.0 B 6.98667E+09 219 219 0.15% 0.0015 10.6 M 1.05836E+07
IHE iShares U.S. Pharmaceutical ETF 331.7 M 3.31707E+08 43 43 0.44% 0.0044 1.5 M 1466930
ITOT iShares Core S&P Total U.S. Stock Market ETF 22.0 B 2.20343E+10 3,546 3546 0.0% 0 742 K 742334
IWM iShares Russell 2000 ETF 41.0 B 4.10203E+10 2,000 2000 0.05% 0.0005 21.9 M 2.19095E+07
IWO iShares Russell 2000 Growth ETF 9.0 B 9.04593E+09 1,146 1146 0.1% 0.001 9.3 M 9313490
IWV iShares Russell 3000 ETF 9.3 B 9.33325E+09 2,893 2893 0.0% 0 341 K 341054
JKK iShares Morningstar Small-Cap Growth ETF 223.9 M 2.23885E+08 250 250 0.15% 0.0015 326 K 325628
FHLC Fidelity MSCI Health Care Index ETF 369 369 0.03% 0.000255146 385 K 384635
ONEQ Fidelity Nasdaq Composite Index Tracking Stock 2.1 B 2.1E+09 1,002 1002 0.02% 0.000185257 389 K 389394